Hemant Surgical Industries Limited

BSE: 543916
Hemant Surgical Industries Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN L33110MH1989PLC051133 Incorporated 27 March 1989 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - BSE: 543916 Public Limited Company healthcare
Data last updated
Market Cap
₹868 Cr
HSIL · BSE
Share Price
₹610.50
+2.20% today
Revenue
₹232 Cr
FY 2025-26 · +117.4% YoY
EBITDA
₹23.23 Cr
Margin 10.0%
Net Profit
₹18.19 Cr
FY 2025-26 · +130.5% YoY
P/E (TTM)
49.4x
P/B 5.3x
Authorised capital
₹16 Cr
Registered with MCA
Paid-up capital
₹14.54 Cr
Issued & subscribed

About Hemant Surgical Industries Limited

Data last updated:

Hemant Surgical Industries Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 27 March 1989 and has been in existence for over 37 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L33110MH1989PLC051133. Its GSTIN is 27AAACH2620J1ZU (Maharashtra). The company holds 2 GST registrations, of which 1 is active. It is a listed company as per MCA records. Its shares are listed on BSE: 543916.

The company has an authorised share capital of ₹16 Cr and a paid-up capital of ₹14.54 Cr. It was formerly known as Hemant Surgical Industries Private Limited. It is led by directors including Hanskumar Shamji Shah (Managing Director) and Hemant Praful Shah (Whole-Time Director).

Its last annual general meeting (AGM) was held on 23 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 502 5th Floor Ecstasy Business Park Co – Op Socteiy Limited J.S.D. Road Mulund West, Mumbai, Maharashtra, India – 400080.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹231.81 Cr, a growth of 117.4% compared to the previous year. For the same year it recorded a net profit of ₹18.19 Cr (net margin 7.8%) and EBITDA of ₹23.23 Cr (EBITDA margin 10%). The net worth stands at ₹137.65 Cr (up 117.9% YoY). Total assets are valued at ₹187.95 Cr (up 98.4% YoY).

The company has about 59 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Hemant Surgical Industries. As per MCA filings, the company has open charges of ₹115.48 Cr and satisfied charges of ₹67.13 Cr on record. Court records list 42 cases involving the company, including 20 filed by the company and 22 filed against it; 18 cases are pending. The company has 15 deals on record (9 market trades, 3 rights issues, 1 funding round), with disclosed funding of ₹50 Lakh; the latest was in August 2025. The company has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 99 overdue payments to 21 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hemantsurgical.com.

Company details

CIN L33110MH1989PLC051133
Registration Number 051133
Incorporation Date 27 March 1989
ROC Mumbai
Listing Status Listed - Listed on BSE (543916)
Company Status Active
Date of Last AGM 23 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant

CIN history

Hemant Surgical Industries has one previous CIN (Corporate Identification Number): U33110MH1989PLC051133. The current CIN is L33110MH1989PLC051133, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L33110MH1989PLC051133Current
U33110MH1989PLC051133Previous
Key People
Hanskumar Shamji Shah Managing Director Hemant Praful Shah Whole-Time Director Kaushik Hans Kumar Shah Cfo

Contact details

Hemant Surgical Industries Limited's registered office is in Mumbai, Maharashtra. Its website is hemantsurgical.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    hemantsurgical.com
  • Social Media
  • Registered Address
    502 5th Floor Ecstasy Business Park Co – Op Socteiy Limited J.S.D. Road Mulund West, Mumbai, Maharashtra, India – 400080
  • Industry
    Healthcare, Medical Consumables & Supplies, Medical & Laboratory Equipment

To see the full contact details of Hemant Surgical Industries Limited, buy the company report.

Comprehensive company report
Hemant Surgical Industries Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Hemant Surgical Industries operates one associated brand: Hemant Surgical Industries. Each brand links to its own profile.

BrandDescriptionWebsite
Hemant Surgical Industries
Manufacturer of dialyzer, fistula needle, heparin solution, face masks, sanitizers, catheter & infudion setshemantsurgical.com

Business activity

The main business activity of Hemant Surgical Industries is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Hemant Surgical Industries Limited, buy the company report.

Financials of Hemant Surgical Industries Limited

FY 2025-26 filings available

Hemant Surgical Industries Limited reported revenue of ₹231.81 Cr (up 117.4% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹232 Cr
+117.4% YoY
EBITDA
₹23.23 Cr
+155.6% YoY
Profit After Tax
₹18.19 Cr
+130.5% YoY
Net Worth
₹138 Cr
+117.9% YoY
Total Assets
₹188 Cr
+98.4% YoY
Total Debt
₹49.67 Cr
+60.1% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25
Income statement
Revenue232107
Revenue growth+117.4%-
EBITDA23.239.09
EBITDA margin+10.0%+8.5%
Profit before tax23.5810.45
Net profit18.197.89
Net profit margin+7.9%+7.4%
EPS (₹)14.947.70
Balance sheet
Total assets18894.75
Net worth13863.17
Total debt49.6731.03
Cash & bank43.849.55
Net working capital10635.24
Cash flow
Cash from operations(32.04)4.63
Cash from investing(2.97)(30.28)
Cash from financing69.3121.85
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue23110710610910459.8256.23
Revenue growth+116.8%+0.9%-3.2%+5.4%+73.1%+6.4%-
EBITDA23.399.2010.4710.556.303.192.67
EBITDA margin+10.1%+8.6%+9.9%+9.7%+6.1%+5.3%+4.8%
Profit before tax23.6310.5612.7810.066.111.490.87
Net profit18.248.019.797.664.611.360.52
Net profit margin+7.9%+7.5%+9.3%+7.0%+4.5%+2.3%+0.9%
EPS (₹)14.987.799.399.9423.0767.842.51
Balance sheet
Total assets18894.3861.9930.7923.1724.8421.25
Net worth13862.9954.8623.3613.1510.367.22
Total debt49.6730.846.757.129.7414.4813.83
Cash & bank43.839.4613.178.465.832.443.60
Net working capital10634.7431.3013.136.3213.195.69
Cash flow
Cash from operations(32.02)4.59(4.15)6.3012.06(4.44)1.65
Cash from investing(9.99)(30.25)(12.37)(2.97)(0.05)(2.27)(1.81)
Cash from financing76.3821.9421.24(0.70)(7.70)4.952.39

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 04 Nov 2026
ParticularsFY 2025-26FY 2024-25
Revenue232107
Revenue growth+117.4%-
Other income5.865.12
Total expenses20997.55
Employee cost0.007.47
EBITDA23.239.09
EBITDA margin+10.0%+8.5%
Depreciation1.541.43
Interest3.972.33
Profit before tax23.5810.45
Tax5.392.43
Net profit18.197.89
Net profit margin+7.9%+7.4%
EPS (₹)14.947.70
ParticularsFY 2025-26FY 2024-25
Equity & liabilities
Share capital13.0410.44
Reserves & surplus11452.73
Shareholders' funds (net worth)13863.17
Minority interest0.000.00
Secured loans49.6430.37
Unsecured loans0.030.66
Total debt49.6731.03
Total liabilities18894.75
Assets
Gross block61.9447.17
Net block53.4439.93
Capital work in progress0.0011.88
Investments0.001.25
Inventories59.0543.14
Sundry debtors67.3520.38
Cash & bank balances43.849.55
Loans & advances22.1815.73
Total current assets19288.80
Total current liabilities86.3253.56
Net working capital10635.24
Total assets18894.75
ParticularsFY 2025-26FY 2024-25
Opening cash9.5513.34
Net cash from operating activities(32.04)4.63
Net cash from investing activities(2.97)(30.28)
Net cash from financing activities69.3121.85
Net change in cash34.29(3.79)
Closing cash43.849.55
ParticularsFY 2025-26FY 2024-25
Growth
Sales growth+117.4%-
EBITDA growth+155.6%-
PBT growth+125.7%+9997.0%
Net income growth+130.5%-
Profitability & leverage
Net income margin+7.9%+7.5%
Return on capital employed-+13.5%
Return on net worth-+12.7%
Debt / equity-0.49
Long-term debt / equity-0.37
Interest cover18.3030.42
Efficiency & per share
Fixed asset turnover-2.26
Inventory turnover-2.47
Debtors turnover-5.23
EPS (₹)14.947.70
Dividend per share (₹)0.000.00
Book value per share (₹)0.0060.51
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue23110710610910459.8256.23
Revenue growth+116.8%+0.9%-3.2%+5.4%+73.1%+6.4%-
Other income5.735.114.312.352.200.830.29
Total expenses20897.3395.1498.6097.2756.6353.56
Employee cost0.007.465.735.514.622.612.60
EBITDA23.399.2010.4710.556.303.192.67
EBITDA margin+10.1%+8.6%+9.9%+9.7%+6.1%+5.3%+4.8%
Depreciation1.521.421.030.850.750.890.49
Interest3.972.330.971.991.641.641.60
Profit before tax23.6310.5612.7810.066.111.490.87
Tax5.392.422.982.421.500.130.35
Net profit18.248.019.797.664.611.360.52
Net profit margin+7.9%+7.5%+9.3%+7.0%+4.5%+2.3%+0.9%
EPS (₹)14.987.799.399.9423.0767.842.51
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital13.0410.4410.447.682.002.002.00
Reserves & surplus11452.5544.4215.6811.157.115.22
Shareholders' funds (net worth)13862.9954.8623.3613.1510.367.22
Secured loans49.6430.186.757.128.1310.2113.12
Unsecured loans0.030.660.000.001.614.270.71
Total debt49.6730.846.757.129.7414.4813.83
Total liabilities18894.3861.9930.7923.1724.8421.25
Assets
Gross block61.6546.8824.0318.6616.3116.7713.50
Net block53.4039.8617.6613.1511.5710.9910.14
Capital work in progress0.0011.880.000.000.000.000.00
Investments0.200.214.930.360.820.011.18
Inventories58.6542.4821.0514.8112.8414.8414.80
Sundry debtors67.2520.3121.7417.2015.664.275.41
Cash & bank balances43.839.4613.178.465.832.443.60
Loans & advances22.2915.7613.336.263.307.104.93
Total current assets19288.0169.2946.7337.6328.6528.74
Total current liabilities86.2153.2737.9933.6031.3115.4623.05
Net working capital10634.7431.3013.136.3213.195.69
Total assets18894.3861.9930.7923.1724.8421.25
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash9.4613.178.465.831.524.201.37
Net cash from operating activities(32.02)4.59(4.15)6.3012.06(4.44)1.65
Net cash from investing activities(9.99)(30.25)(12.37)(2.97)(0.05)(2.27)(1.81)
Net cash from financing activities76.3821.9421.24(0.70)(7.70)4.952.39
Net change in cash34.37(3.71)4.712.634.31(1.75)2.23
Closing cash43.839.4613.178.465.832.443.60
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+116.8%+0.9%-3.2%+5.4%+73.1%+6.4%-
EBITDA growth+154.2%-12.1%-0.8%+67.5%+97.5%+19.5%-
PBT growth+123.8%-17.4%+27.0%+64.7%+310.1%+71.3%-29.3%
Net income growth+127.7%-18.2%+27.8%+66.2%+239.0%+161.5%-
Revenue CAGR (3Y)+28.4%+0.9%+20.9%+24.7%+23.0%+5.8%-
EBITDA CAGR (3Y)+30.4%+13.5%+48.6%+58.1%+33.1%+8.8%-
Profitability & leverage
Net income margin+7.9%+7.6%+9.3%+7.0%+4.5%+2.3%+0.9%
Return on capital employed-+16.5%+29.6%+44.7%+32.3%+13.6%+12.2%
Return on net worth-+13.8%+25.1%+41.9%+39.2%+15.5%+6.8%
Debt / equity-0.320.180.461.031.611.70
Long-term debt / equity-0.230.080.200.621.020.94
Interest cover18.1529.9510.2820.5229.5571.3073.39
Efficiency & per share
Fixed asset turnover-3.004.956.246.263.955.25
Inventory turnover-3.355.897.907.484.044.71
Debtors turnover-5.075.426.6410.3912.3610.34
EPS (₹)14.987.799.399.9423.0767.842.51
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)0.0060.3452.5530.4165.74455.6436.10

To see the full year-wise statements and ratios of Hemant Surgical Industries Limited, buy the company report.

Board of directors and KMP of Hemant Surgical Industries Limited

Hemant Surgical Industries Limited currently reports 5 directors and 1 key managerial person. 7 former directors have served the organization.

Current Directors and KMP
NameDesignationAppointment DateTenureStatus
Hanskumar Shamji Shah
Also directs: Diaso Diagnostics LLP, Solar Opto-Medic Private Limited, Ikigai Medequipments Private Limited and 3 more
Managing Director22 Feb 199432 Years 8 MonthsCurrent
Hemant Praful Shah
Also directs: Solar Opto-Medic Private Limited
Whole-Time Director19 Sep 200026 Years 1 MonthsCurrent
Kshama Ronak Dharnidharka
Also directs: Copains Consultants LLP, Patil Automation Limited
Additional Director19 Dec 20241 Years 10 MonthsCurrent
Kaushik Hans Kumar Shah
Also directs: Diaso Diagnostics LLP, Solar Opto-Medic Private Limited, Ikigai Medequipments Private Limited and 4 more
Cfo17 Dec 20223 Years 10 MonthsCurrent
Nehal Vishal ThakkarDirector20 Dec 20223 Years 10 MonthsCurrent
Manish Kankani
Also directs: Deepak Chemtex Limited, Manisha Textiles Limited, Msafe Equipments Limited
Additional Director28 Aug 20251 Years 2 MonthsCurrent
View all directors and KMP

Auditor

Hemant Surgical Industries Limited is audited by A D V & Associates for the financial year 2024.

Auditor firmFinancial yearFirm registration number
A D V & AssociatesFY 2024128045W

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 58.90%, foreign institutional investors hold 0.20%, domestic institutional investors hold 10.70% and retail and other public shareholders hold 30.20%.

Promoters: 58.90%DII (Domestic Institutional): 10.70%FII (Foreign Institutional): 0.20%Retail & Others: 30.20%
Sep 2026
QUARTER
58.90% Promoters
10.70% DII (Domestic Institutional)
0.20% FII (Foreign Institutional)
30.20% Retail & Others
Promoter holding - history
Now 58.90% · Sep 2026High 73.60% · Dec 2025Low 58.90% · Jun 2026
57%61.5%66%70.5%75%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 73.60%Mar 2026: 73.60%Jun 2026: 58.90%Sep 2026: 58.90%73.60%58.90%58.90%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters58.90%58.90%73.60%73.60%
Public41.10%41.10%26.40%26.40%

Charges & borrowings

Open charges
₹115.48 Cr
Satisfied charges
₹67.13 Cr
Breakdown by lending institutions
Others₹50.57 Cr
Standard Chartered Bank₹38.30 Cr
Yes Bank Limited₹23.37 Cr
Sidbi₹2.47 Cr
Hdfc Bank Limited₹0.77 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
29 May 2026101311165Others₹49.5 CrOpen
19 Sep 2025101161890Yes Bank Limited₹3.45 CrOpen
01 Mar 2025101092538Others₹18.98 LakhOpen
05 Jul 2024100958486Yes Bank Limited₹92.08 LakhOpen
15 Jun 2024100941323Others₹50 LakhOpen

To see the full charge records of Hemant Surgical Industries Limited, buy the company report.

Total charge records: 38 View all charges

Deals & funding

Hemant Surgical Industries Limited has 15 deals on record (9 market trades, 3 rights issues, 1 funding round), with disclosed funding of ₹50 Lakh; the latest was in August 2025.

Total deals
15
Market trades
9
Rights issues
3
Funding round
1
IPO
1
Disclosed funding
₹50 Lakh

Deals on record (5 of 15)

WhenDealAmountParties
Jun 2023Market trade₹3.88 CrBuyer: an individual
Seller: Multiplier Share and Stock Advisors Private Limited , Mansi Share and Stock Broking Private Limited , Setu Securities Private Limited
Jun 2023Market trade₹7.44 CrBuyer: Multiplier Share and Stock Advisors Private Limited , Mansi Share and Stock Broking Private Limited , Setu Securities Private Limited
Seller: Multiplier Share and Stock Advisors Private Limited , Mansi Share and Stock Broking Private Limited , Setu Securities Private Limited
Jun 2023Market trade₹1.15 CrSeller: Multiplier Share and Stock Advisors Private Limited
Jun 2023Market trade₹8.2 CrBuyer: Multiplier Share and Stock Advisors Private Limited , Mansi Share and Stock Broking Private Limited , Setu Securities Private Limited
May 2023IPO₹24.84 CrInvestors: IPO Shareholder - Hemant Surgical Industries Limited, India Ahead Venture Fund, Carnelian Structural Shift Fund

To see the full deal history of Hemant Surgical Industries Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Hemant Surgical Industries Limited was last rated by Icra on 26 Apr 2021.

Rating agencyRated onRating
Icra26 Apr 2021

To see the full credit ratings and regulatory alerts of Hemant Surgical Industries Limited, buy the company report.

MSME payment delays

Hemant Surgical Industries Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 99 overdue payments to 21 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 21)

SupplierAmount dueDue sinceReported on
Fppi Private Limited
Royal Aircon Private Limited
Mono Industries
an individual supplier
Everrtech Software Pvt Ltd

To see the full MSME payment records of Hemant Surgical Industries Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Hemant Surgical Industries Limited has a workforce of 59 employees on its EPFO records as of Sep 24, 2025, across 1 active EPFO establishment.

Employee count
59
Active EPFO establishments
1
Employee growth
11.32%

GST

Hemant Surgical Industries has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
27AAACH2620J1ZUMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Hemant Surgical Industries Limited, buy the company report.

Recent activity

Hemant Surgical Industries Limited has 12 board changes on record since 1994: 7 appointments and 5 cessations. The latest: Manish Kankani was appointed as Additional Director on 28 Aug 2025.

Charges
A charge with Others amounted to Rs. 49.50 Cr with Charge ID 101311165 was registered on 29 May 2026.
Filing
Hemant Surgical Industries Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai I.
Charges
A charge registered on 31 Jan 2025 via Charge ID 101043063 with Others was fully satisfied on 23 Mar 2026.
Charges
A charge registered on 31 Jan 2025 via Charge ID 101043067 with Others was fully satisfied on 16 Mar 2026.
Charges
A charge registered on 31 Jan 2025 via Charge ID 101043072 with Others was fully satisfied on 16 Mar 2026.
Charges
A charge with Standard Chartered Bank of Rs. 34.25 Cr registered on 25 May 2022 with Charge ID 100580972 was modified on 13 Nov 2025.
AGM
Hemant Surgical Industries Limited last Annual general meeting of members was held on 23 Sep 2025 as per latest MCA records.
Charges
A charge with Yes Bank Limited amounted to Rs. 3.45 Cr with Charge ID 101161890 was registered on 19 Sep 2025.
Appointed
Manish Kankani was appointed as Additional Director.
Charges
A charge registered on 10 Oct 2024 via Charge ID 101022041 with Others was fully satisfied on 21 Aug 2025.
Charges
A charge registered on 16 Sep 2023 via Charge ID 100789847 with Hdfc Bank Limited was fully satisfied on 11 Aug 2025.
Charges
A charge registered on 29 Aug 2023 via Charge ID 100786256 with Others was fully satisfied on 04 Jul 2025.

75 earlier events are in the company report.

Frequently asked questions

Hemant Surgical Industries is an active public limited company based in Mumbai, Maharashtra, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 27 March 1989 (37+ years old) and is registered under CIN L33110MH1989PLC051133. Listed on BSE: 543916.

Hemant Surgical Industries reported revenue of ₹231.81 Cr for FY 2025-26 (up 117.4% YoY) based on consolidated financials.

Hemant Surgical Industries has 6 current directors and KMP:

The latest financial statements of Hemant Surgical Industries on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 23 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Hemant Surgical Industries is 27AAACH2620J1ZU, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Hemant Surgical Industries is L33110MH1989PLC051133. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Hemant Surgical Industries is a listed company as per MCA records. Its shares are listed on BSE (code: 543916).

Hemant Surgical Industries has 42 court cases on record: 20 filed by the company and 22 filed against it. 18 are pending. Most are in the district courts.

Hemant Surgical Industries was incorporated on 27 March 1989, making it 37+ years old. It is registered with the Registrar of Companies, Mumbai.

Hemant Surgical Industries has 15 deals on record (9 market trades, 3 rights issues, 1 funding round), with disclosed funding of ₹50 Lakh; the latest was in August 2025.

Manish Kankani was appointed as Additional Director on 28 Aug 2025. Kshama Ronak Dharnidharka was appointed as Additional Director on 19 Dec 2024. Sourabh Ajmera ceased to be Director on 19 Dec 2024. Hemant Surgical Industries has 12 board changes on record in total.